Abstracts Archive - Page 34 of 1683 - ATC Abstracts

2022 American Transplant Congress
Safety and Efficacy of SGLT-2 Inhibitors in Solid Organ Transplant Recipients
E. Heiman, D. Blanco, A. Webb
Pharmacy, Tampa General Hospital, Tampa, FL
*Purpose: Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been shown to improve glycemic control, blood pressure, cardiovascular mortality, and preserve kidney function in the general population.…
2022 American Transplant Congress
Invasive Fungal Infections Associated with COVID-19 Infections in Solid Organ Transplant Recipients
R. Alameer, M. Nguyen, P. Samanta
Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Invasive fungal infection (IFI) complicating Coronavirus disease of 2019 (COVID-19) has been increasingly recognized. IFI is a common opportunistic infection in solid organ transplant…
2022 American Transplant Congress
Deceased Donor Kidney Transplantation from Donors with Acute Kidney Injury: Realities and Costs
S. Iskhagi¹, R. Shahbazov¹, A. Ball¹, S. Loerzel¹, E. Shaban², B. Gallay², R. Hod Dvorai³, J. Leggat², M. Hanlon¹, R. Saidi¹
¹Department of Surgery, Division of Transplantation, SUNY Upstate Medical University, Syracuse, NY, ²Department of Medicine, Division of Nephrology, SUNY Upstate Medical University, Syracuse, NY, ³Department of Pathology and Laboratory Medicine, SUNY Upstate Medical University, Syracuse, NY
*Purpose: The use of kidneys from deceased donors with acute kidney injury (AKI) is one of the options to expand donor pool. Several studied have…
2022 American Transplant Congress
Outcomes After Deceased Donor Kidney Transplantation Utilizing Kidney Allografts with Marginal Perfusion Parameters: A Single-Center Experience
P. N. Chotai¹, A. Logan², F. Siddiqui³, A. Schenk⁴, G. Bumgardner⁵, G. L. Brock², A. El-Hinnawi⁵, A. Rajab⁶, K. Washburn⁷, N. Singh²
¹Division of Transplantation, Department of General Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, ²The Ohio State University Wexner Medical Center, Columbus, OH, ³Ohio State University, Bloomfield, NJ, ⁴Ohio State University Wexner Medical Center, Bexley, OH, ⁵Ohio State University, Columbus, OH, ⁶Ohio State University Wexner Medical Center, Columbus, OH, ⁷The Ohio State University, Columbus, OH
*Purpose: To study outcomes of deceased donor kidney transplantation (DDKT) in recipients of kidney allografts with poor perfusion parameters.*Methods: This is a retrospective, single center…
2022 American Transplant Congress
The Impact of the New Allocation System of Kidney Transplantation on a Single Institution
M. Eltemamy, Y. Lin, M. Khalil, S. Agrawal, V. Krishnamurthi, A. Wee
The Cleveland Clinic, Cleveland, OH
*Purpose: The new kidney allocation system went into effect in the middle of March 2021. The consequences of this new system affected transplant centers differently,…
2022 American Transplant Congress
Site-Directed Mutagenesis as a Tool to Investigate Immunogenicity of HLA Epitopes for Humoral Alloreactivity
C. H. Maguire¹, P. Crivello², A. Tambur¹
¹Northwestern University, Chicago, IL, ²University Hospital Essen, Essen, Germany
*Purpose: Molecular mismatch load (MML) analysis has been a proposed approach to assess donor/recipient compatibility in support of organ allocation algorithms. While conceptually appealing, MML…
2022 American Transplant Congress
Cardiovascular Outcomes of Kidney Transplant Recipients Receiving Belatacept Compared to a Matched Tacrolimus
Y. Kim¹, J. Marvin¹, K. Belfield¹, G. Girone¹, R. Formica², E. Cohen¹
¹Pharmacy, Yale New Haven Hospital, New Haven, CT, ²Section of Nephrology, Yale School of Medicine, New Haven, CT
*Purpose: Tacrolimus (TAC), a calcineurin inhibitor (CNI), is the backbone of maintenance immunosuppression in kidney transplant recipients (KTR) but has been associated with cardiovascular (CV)…
2022 American Transplant Congress
Sirolimus Regimens After Kidney Transplantation: Role of Pre-Transplant Risk Factors in Modifying the Risk of Mortality in Adult Recipients
A. Santos¹, H. Ibrahim¹, M. A. Leghrouz¹, X. Wen²
¹University of Florida, Gainesville, FL, ²University of Rhode Island, Kinston, RI
*Purpose: We aimed to investigate the role of risk factors in modifying the association of sirolimus with mortality in kidney transplant (KT) recipients (KTRs).*Methods: Using…
2022 American Transplant Congress
Defects in Kim-1 Do Not Result In Delayed Graft Function After Kidney Transplantation
R. S. Suri¹, J. Lee², M. Ban³, B. Shrum², O. Z. Ismail⁴, S. Leckie⁵, A. McIntyre³, Q. Xu⁶, S. H. Lee², S. de Chickera², R. A. Hegele², L. Gunaratnam²
¹Research Institute of the McGill University Health Center, Montreal, QC, Canada, ²Schulich School of Medicine and Dentistry, Western University, Lodnon, ON, Canada, ³Robarts Research Institute, Lodnon, ON, Canada, ⁴University of Alberta, Edmonton, AB, Canada, ⁵London Health Sciences Centre, Lodnon, ON, Canada, ⁶University of Pittsburg Medical Center, Pittsburg, PA
*Purpose: Tissue repair is critical to restore organ function after ischemia-reperfusion injury (IRI) during transplantation. During renal injury, upregulation of kidney injury molecule-1 (KIM-1) transforms…
2022 American Transplant Congress
Preferred Language And Disease Severity Predict Evaluation For Liver Transplantation Among Patients Admitted With Alcoholic Hepatitis
D. J. Cloonan¹, J. Broekhuis², T. Coe¹, S. Criss³, S. Li³, E. Bethea¹, H. Yeh¹, L. Dageforde¹
¹Massachusetts General Hospital/Harvard Medical School, Boston, MA, ²Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, ³Harvard Medical School, Boston, MA
*Purpose: Liver transplantation (LT) for alcoholic hepatitis (AH) without a sobriety period is a relatively new practice. While AH patients are no longer categorically excluded…